skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Mostrar Somente
Refinado por: idioma: Norueguês remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
An independent poor-prognosis subtype of breast cancer defined by a distinct tumor immune microenvironment
An independent poor-prognosis subtype of breast cancer defined by a distinct tumor immune microenvironment
Material Type:
Artigo 		Adicionar ao Meu Espaço

An independent poor-prognosis subtype of breast cancer defined by a distinct tumor immune microenvironment

Tekpli, Xavier ; Lien, Tonje ; Røssevold, Andreas Hagen ; Nebdal, Daniel ; Borgen, Elin ; Ohnstad, Hege Oma ; Kyte, Jon Amund ; Vallon-Christersson, Johan ; Fongaard, Marie ; Due, Eldri Undlien ; Svartdal, Lisa Gregusson ; Sveli, My Anh Tu ; Garred, Øystein ; Frigessi, Arnoldo ; Sahlberg, Kristine Kleivi ; Sørlie, Therese ; Russnes, Hege G ; Naume, Bjørn ; Kristensen, Vessela N

Nature communications, 2019-12, Vol.10 (1), p.5499-14, Article 5499 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
2
Liver x receptor alpha drives chemoresistance in response to side-chain hydroxycholesterols in triple negative breast cancer
Liver x receptor alpha drives chemoresistance in response to side-chain hydroxycholesterols in triple negative breast cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Liver x receptor alpha drives chemoresistance in response to side-chain hydroxycholesterols in triple negative breast cancer

Hutchinson, Samantha A ; Websdale, Alex ; Cioccoloni, Giorgia ; Røberg-Larsen, Hanne ; Lianto, Priscilia ; Kim, Baek ; Rose, Ailsa ; Soteriou, Chrysa ; Pramanik, Arindam ; Wastall, Laura M ; Williams, Bethany J ; Henn, Madeline A ; Chen, Joy J ; Ma, Liqian ; Moore, J Bernadette ; Nelson, Erik ; Hughes, Thomas A ; Thorne, James L

Oncogene, 2021-04, Vol.40 (16), p.2872-2883 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
3
Safety of everolimus plus exemestane in patients with hormone-receptor–positive, HER2–negative locally advanced or metastatic breast cancer progressing on prior non-steroidal aromatase inhibitors: primary results of a phase IIIb, open-label, single-arm, expanded-access multicenter trial (BALLET)
Safety of everolimus plus exemestane in patients with hormone-receptor–positive, HER2–negative locally advanced or metastatic breast cancer progressing on prior non-steroidal aromatase inhibitors: primary results of a phase IIIb, open-label, single-arm, expanded-access multicenter trial (BALLET)
Material Type:
Artigo 		Adicionar ao Meu Espaço

Safety of everolimus plus exemestane in patients with hormone-receptor–positive, HER2–negative locally advanced or metastatic breast cancer progressing on prior non-steroidal aromatase inhibitors: primary results of a phase IIIb, open-label, single-arm, expanded-access multicenter trial (BALLET)

Jerusalem, G. ; Mariani, G. ; Ciruelos, E.M. ; Martin, M. ; Tjan-Heijnen, V.C.G. ; Neven, P. ; Gavila, J.G. ; Michelotti, A. ; Montemurro, F. ; Generali, D. ; Simoncini, E. ; Lang, I. ; Mardiak, J. ; Naume, B. ; Camozzi, M. ; Lorizzo, K. ; Bianchetti, S. ; Conte, P.

Annals of oncology, 2016-09, Vol.27 (9), p.1719-1725 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
4
Radium-223 in women with hormone receptor-positive bone-metastatic breast cancer receiving endocrine therapy: pooled analysis of two international, phase 2, randomized, double-blind, placebo-controlled trials
Radium-223 in women with hormone receptor-positive bone-metastatic breast cancer receiving endocrine therapy: pooled analysis of two international, phase 2, randomized, double-blind, placebo-controlled trials
Material Type:
Artigo 		Adicionar ao Meu Espaço

Radium-223 in women with hormone receptor-positive bone-metastatic breast cancer receiving endocrine therapy: pooled analysis of two international, phase 2, randomized, double-blind, placebo-controlled trials

Rugo, Hope S. ; Van Poznak, Catherine H. ; Neven, Patrick ; Danielewicz, Iwona ; Lee, Soo Chin ; Campone, Mario ; Chik, Jeannie Y. K. ; Vega Alonso, Estela ; Naume, Bjørn ; Brain, Etienne ; Siegel, Jonathan M. ; Li, Rui ; Uema, Deise ; Wagner, Volker J. ; Coleman, Robert E.

Breast cancer research and treatment, 2024-04, Vol.204 (2), p.249-259 [Periódico revisado por pares]

New York: Springer US

Texto completo disponível

Citações Citado por
5
Atezolizumab plus anthracycline-based chemotherapy in metastatic triple-negative breast cancer: the randomized, double-blind phase 2b ALICE trial
Atezolizumab plus anthracycline-based chemotherapy in metastatic triple-negative breast cancer: the randomized, double-blind phase 2b ALICE trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Atezolizumab plus anthracycline-based chemotherapy in metastatic triple-negative breast cancer: the randomized, double-blind phase 2b ALICE trial

Røssevold, Andreas Hagen ; Andresen, Nikolai Kragøe ; Bjerre, Christina Annette ; Gilje, Bjørnar ; Jakobsen, Erik Hugger ; Raj, Sunil Xavier ; Falk, Ragnhild Sørum ; Russnes, Hege Giercksky ; Jahr, Thea ; Mathiesen, Randi Ruud ; Lømo, Jon ; Garred, Øystein ; Chauhan, Sudhir Kumar ; Lereim, Ragnhild Reehorst ; Dunn, Claire ; Naume, Bjørn ; Kyte, Jon Amund

Nature medicine, 2022-12, Vol.28 (12), p.2573-2583 [Periódico revisado por pares]

United States: Nature Publishing Group

Texto completo disponível

Citações Citado por
6
Functional design of pH-responsive folate-targeted polymer-coated gold nanoparticles for drug delivery and in vivo therapy in breast cancer
Functional design of pH-responsive folate-targeted polymer-coated gold nanoparticles for drug delivery and in vivo therapy in breast cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Functional design of pH-responsive folate-targeted polymer-coated gold nanoparticles for drug delivery and in vivo therapy in breast cancer

Mahalunkar, Sneha ; Yadav, Amit Singh ; Gorain, Mahadeo ; Pawar, Vinay ; Braathen, Ranveig ; Weiss, Siegfried ; Bogen, Bjarne ; Gosavi, Suresh W ; Kundu, Gopal C

International journal of nanomedicine, 2019-01, Vol.14, p.8285-8302 [Periódico revisado por pares]

New Zealand: Dove Medical Press Limited

Texto completo disponível

Citações Citado por
7
Fatigue During and After Breast Cancer Therapy—A Prospective Study
Fatigue During and After Breast Cancer Therapy—A Prospective Study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Fatigue During and After Breast Cancer Therapy—A Prospective Study

Reinertsen, Kristin V., MD, PhD ; Engebraaten, Olav, MD, PhD ; Loge, Jon H ; Cvancarova, Milada, MSc, PhD ; Naume, Bjørn ; Wist, Erik ; Edvardsen, Hege, MSc, PhD ; Wille, Elisabeth, MSc ; Bjøro, Trine ; Kiserud, Cecilie E., MD, PhD

Journal of pain and symptom management, 2017-03, Vol.53 (3), p.551-560 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
8
The proapoptotic gene interferon regulatory factor-1 mediates the antiproliferative outcome of paired box 2 gene and tamoxifen
The proapoptotic gene interferon regulatory factor-1 mediates the antiproliferative outcome of paired box 2 gene and tamoxifen
Material Type:
Artigo 		Adicionar ao Meu Espaço

The proapoptotic gene interferon regulatory factor-1 mediates the antiproliferative outcome of paired box 2 gene and tamoxifen

Wang, Shixiong ; Somisetty, Venkata S ; Bai, Baoyan ; Chernukhin, Igor ; Niskanen, Henri ; Kaikkonen, Minna U ; Bellet, Meritxell ; Carroll, Jason S ; Hurtado, Antoni

Oncogene, 2020-10, Vol.39 (40), p.6300-6312 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
9
Inhibition of O-GlcNAc transferase activates tumor-suppressor gene expression in tamoxifen-resistant breast cancer cells
Inhibition of O-GlcNAc transferase activates tumor-suppressor gene expression in tamoxifen-resistant breast cancer cells
Material Type:
Artigo 		Adicionar ao Meu Espaço

Inhibition of O-GlcNAc transferase activates tumor-suppressor gene expression in tamoxifen-resistant breast cancer cells

Barkovskaya, Anna ; Seip, Kotryna ; Prasmickaite, Lina ; Mills, Ian G ; Moestue, Siver A ; Itkonen, Harri M

Scientific reports, 2020-10, Vol.10 (1), p.16992-16992, Article 16992 [Periódico revisado por pares]

England: Nature Publishing Group UK

Texto completo disponível

Citações Citado por
10
RAB5A expression is a predictive biomarker for trastuzumab emtansine in breast cancer
RAB5A expression is a predictive biomarker for trastuzumab emtansine in breast cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

RAB5A expression is a predictive biomarker for trastuzumab emtansine in breast cancer

Engebraaten, Olav ; Yau, Christina ; Berg, Kristian ; Borgen, Elin ; Garred, Øystein ; Berstad, Maria E B ; Fremstedal, Ane S V ; DeMichele, Angela ; Veer, Laura van 't ; Esserman, Laura ; Weyergang, Anette

Nature communications, 2021-11, Vol.12 (1), p.6427-6427, Article 6427 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Recursos Online (39)
  2. Revistas revisadas por pares (57)

Data de Publicação 

De até
Refinar
  1. Antes de1975  (9)
  2. 1975Até1990  (7)
  3. 1991Até2002  (7)
  4. 2003Até2016  (8)
  5. Após 2016  (29)
  6. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.